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confirm differences in gene expression. We found that he-
patic gene expression (fold ± SEM) of Gamma-Butyrobetaine 
Hydroxylase 1 (Bbox1) was higher in vehicle-treated ani-
mals (1 ± 0.60) compared to dieldrin-treated animals (0.29 ± 
0.12). Bbox1 catalyzes the last step in the L-carnitine bi-
osynthetic pathway, which is necessary for mitochondrial 
beta-oxidation. Dieldrin-induced reduction in L-carnitine 
production may be a critical factor in adult reproductive 
function. Further, Protein-L-Isoaspartate (D-Aspartate) 
O-Methyltransferase Domain Containing Protein 1 
(Pcmtd1) was higher (1± 0.76) in vehicle-treated animals 
compared to dieldrin-treated animals (0.13  ± 0.044), and 
DENN Domain Containing 5B (Dennd5b) was also found to 
be higher in vehicle-treated (1 ± 0.39) compared to dieldrin-
treated (0.28 ± 0.10) turtles. We found that dieldrin expo-
sure did not alter gene expression of Cytochrome p450 1a 
(Cyp1a) a marker of aryl hydrocarbon receptor signaling, or 
Vitellogenin 2 (Vtg2) a marker of estrogen signaling. In our 
RNAseq analysis we unexpectedly discovered a hepacivirus 
infecting T. scripta. In the dieldrin-treated group, we used 
QPCR to examine gene expression of potential markers of 
hepacivirus infection. Neither Interleukin 1 Beta (Il-1β), 
SMAD Family Member 6 (Smad6), C-C Motif Chemokine 
Ligand 5 (Ccl5), or TNF Receptor Superfamily Member 9 
(Tnfrsf9) was found to differ in turtles carrying the virus, 
compared to non-infected animals. In conclusion, we found 
that developmental dieldrin exposure of T. scripta slightly 
reduces neonatal expression of several gene transcripts 
which may be correlated to adult reproductive fitness.
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Introduction/Background: Pheochromocytomas are 
rare neoplasms, occurring in less than 0.2% of the popu-
lation. The classic triad of symptoms includes hyperten-
sion, headaches and sweating. An increasing number of 
patients with pheochromocytomas that are diagnosed at a 
pre-symptomatic stage.Clinical Case A 69 yo male being 
worked up for hematuria and possible bladder cancer was 
referred to endocrinology due to a 3 cm x 3 cm right adrenal 
“incidentaloma.” The mass was noted to be heterogeneously 
enhancing on CT adrenal protocol, suggesting pheochromo-
cytoma, adrenal carcinoma or metastasis. He endorsed no 
clinical symptoms of hormone excess and blood pressure 
was controlled HCTZ. He was found to have elevated serum 
metanephrines (184 pg/mL, nl <57) and noremetanephrine 
(608 pg/dL, nl <148) and total metanephrines (792 pg/dL, 
nl <205). Other hormonal determinations were normal in-
cluding cortisol (9AM, 8.97 ug/dL, nl 3-22), DHEAS 66 mcg/
dL (25-240), estradiol 23 pg/mL (<39), 17 OHD 60 ng/dL, 
ACTH 37 (6-50), free testosterone 43.6, total testosterone 
396, androstenedione 63 (20-220). Further testing revealed 
24 hour urine metanephrine and catecholeamines; urinary 
metanehrine 2025, noremetanephrine 1729, total 2442 and 
epinephrine 48, norepinephrine 336 and dopamine 112 
which were 2-3 times the upper limit of normal. Because 
the patient consumed significant amount of caffeine (10 
cups of coffee and cola daily), these studies were repeated 
after caffeine washout. Repeat serum testing revealed 
metanephrine at the upper limit of normal (metanephrine 
47, noremetanphrine 146, respectively). Chromogranin 
A levels were elevated before (626 units) and after PPI dis-
continuation, (539 units, nl 25-140). Given the biochem-
ical results and size of mass, he was referred him surgical 
resection. He was treated pre-operatively with doxazosin 
and underwent an uncomplicated right adrenalectomy via 
posterior right retroperitoneoscopic. Pathology was con-
sistent with pheochromocytoma without capsular invasion. 
Immunohistochemical stains were characteristic of pheo-
chromocytoma, positive for synaptophysin, chromogranin, 
and S100 but negative for Cytokeratin AE1/AE3 and 
calretinin. Conclusion: We present the case of a patient 
with a clinically asymptomatic pheochromocytoma. The di-
agnosis was supported by elevations in chromogranin and 
catecholamine metabolites, although the latter results were 
mixed and clouded by potential confounding factors such 
as heavy caffeine intake. The case demonstrates that with 
early detection, screening should include patients with no 
symptoms and otherwise low risk of disease. Decisions on 
surgical resection should be based on clinical suspicion, 
symptoms, imaging, tumor size and biochemical findings 
given the aggressive nature of these tumors and their ma-
lignant potential.
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The growth arrest-specific 5 (gas5) gene encodes a long 
non-coding RNA (lncRNA) that is required for normal 
growth arrest, slows down the cell cycle, controls apoptosis, 
and is required for the inhibition of cell growth by mTOR 
inhibitors such as rapamycin. In agreement with this role 
in regulating cell proliferation, Gas5 expression is reduced 
and acts as a tumor suppressor in numerous cancers, in-
cluding B-cell lymphoma and leukemia. At its 3’ terminal 
end (nucleotides 546-566) Gas5 contains a predicted 
stem-loop structure that specifically interacts with ste-
roid receptors (SRs) and blocks DNA-dependent steroid 
signalling. In steroid-sensitive cancer cells such as prostate 
cancers this SR binding motif is responsible for Gas5 effects 
on cell growth. This is not true in other cell types, how-
ever, where proliferation is not strongly dependent on SR 
signaling (e.g. leukemic T cells). Therefore, other regions in 
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Gas5 must be active and use different mechanisms to reg-
ulate cell survival. We have used SHAPE chemical probing 
to analyze the secondary structure of Gas5 in vitro and in 
cellulo. We find that the secondary structure of endogenous 
Gas5 resembles that of in vitro transcribed Gas5 RNA. The 
molecule contains three separate structural modules: a 
5’ module with low secondary structure content, a highly 
structured core module, and the SR binding module, which 
forms separate from the rest of the molecule close to its 3’ 
end. Functional studies in leukemic T cells show that the 
5’ module mediates Gas5’s role in inhibiting basal cell sur-
vival and slowing the cell cycle, whereas the core module 
is required for mediating the effects of mTOR inhibition. 
These results confirm that the Gas5 structural modules 
function independently in cells and each module acts under 
different cellular conditions, likely using different molec-
ular mechanisms. RNA pull-downs from cell lysates using 
the identified modules and full-length RNA identified 
proteins preferentially associated with each module. 
Proteins preferentially associated with the 5’ terminal re-
gion are enriched in splicing and RNA processing factors. 
The structured central region preferentially interacts with 
proteins involved in chromosome organization such as the 
SWI/SNF family of nucleosome remodeling complexes.
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The insulin-like growth factor type 1 receptor (IGF-1R) 
is now thought to have a dual function in breast cancer. 
Several studies have shown overexpression of the IGF-1R 
pathway results in increased tumor cell proliferation 
and survival. Recent loss-of-function models have shown 
decreased mammary tumorigenesis latency and increased 
metastasis. These recent studies correlate with analyses of 
human patient datasets identifying worse overall survival 
with low IGF-1R expression. Similarly, inhibition of IGF-1R 
in the clinic has had no affect or has led to worse outcomes 
supporting the hypothesis that the IGF-1R may have tumor 
suppressive properties. Our prior published studies re-
vealed loss of IGF-1R function results in heightened tumor 
epithelial stress, which alters the tumor microenvironment 
to be permissive for metastasis. Therefore, we asked does 
the loss of IGF-1R inherently change the tumor epithelium 
or is it simply the alterations of the microenvironment 
that lead to a metastatic primary tumor? We first analyzed 
cell invasion of primary tumor epithelial cells from a 
mouse tumor model driven by the Wnt1 oncogene (MMTV-
Wnt1) and with reduced IGF-1R signaling by expression 
of a dominant-negative transgene (MMTV-dnIGF-1R). 
Epithelial cells from the MMTV-Wnt1/dnIGF-1R (bigenic) 
tumors invaded at the same rate as MMTV-Wnt1 tumor 
epithelial cells by tail vein injection suggesting invasive 
capacity is unchanged with reduced IGF-1R signaling. 
Interestingly, size of lung micrometastases from tail vein 
injected bigenic tumor epithelial cells was significantly 
reduced and the number also decreased over time in part 
due to a proliferative defect determined by immunostaining 
for pH3. Similarly, bigenic primary tumor epithelial cells 
injected into the mammary gland fat pad failed to form 
tumors suggesting alterations in cell adhesion. Consistent 
with this observation, E-cadherin gene and protein ex-
pression were decreased in the bigenic tumor epithelium 
compared to MMTV-Wnt1 tumors. In vitro analysis of cell 
adhesion in MMTV-Wnt1 primary epithelial cells resulted 
in both K8+ (luminal) and K14+ (basal) tumor epithelial 
cells adherence, while only K14+ cells from bigenic tumors 
adhered to collagen. Similarly, the lung micrometastases 
from tail vein injections exhibited predominantly K14+ 
cells. Analysis of MMTV-Wnt1 and bigenic primary tumors 
using single cell RNAseq revealed alterations in both 
stromal and epithelial populations that may contribute to 
bigenic primary tumor growth and metastasis. These data 
support the conclusion that inhibiting IGF-1R signaling 
results in both alterations to the tumor epithelium (partial 
EMT) and microenvironment that result in metastasis, but 
also, that the IGF-1R deficient metastatic cells need a niche 
or paracine signaling to proliferate.
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Background: Transient transaminitis is a rarely discussed 
complication of uncontrolled diabetes mellitus (DM). 
Known as glycogenic hepatopathy (GH), it is belived to be 
caused by build-up of glycogen in hepatocytes. Recognized 
as benign and reversible, GH is associated with hepato-
megaly (>90% cases) and primarily seen in patients with 
type 1 DM during periods of inadequate hyperglycemic 
control. Differential diagnoses include glycogen storage 
diseases, nonalcoholic fatty liver disease, hepatosclerosis, 
autoimmune hepatitis, hemochromatosis, Wilson disease, 
and acute viral hepatitis.1
Case Report: A 26-year-old African American female with 
type 1 DM and sickle cell presented on multiple occasions 
to the emergency department with abdominal pain associ-
ated with nausea, vomiting and diarrhea. Initial labs con-
sistently included glucose levels >600 mg/dL (70-105 mg/
dL), elevated anion gap ranging 20-40s mEq/L (5-15 
mEq), and severe metabolic acidosis reflective of diabetic 
ketoacidosis (DKA). Labs were also significant for repeated 
mild transaminitis despite adequate fluid hydration.
After several admissions, we observed a distinct pattern of 
mild transaminitis that directly fluctuated with her levels 
of blood glucose. With some minor lag, the patient’s liver 
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